Business secretary Jonathan Reynolds is facing growing pressure to refuse repayment of almost £1bn in loans owed to the Chinese former owners of British Steel. British Steel owed just under £1bn to
More
Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist 2 mg/1 mL due to a label mix-up. The recall centres on
More
Takeda Pharmaceutical has secured a significant regulatory milestone after its first-in-class orexin treatment received approval from the US Food and Drug Administration for narcolepsy. The approval marks a major breakthrough in narcolepsy
More
The 21st Century ROAD to Housing Act became Public Law 119-101 on July 11, 2026, taking effect without the President’s signature after the ten-day period under Article I, Section 7 elapsed. The
More
California’s housing crisis continues to intensify, prompting a landmark appellate ruling that clarifies when coastal jurisdictions can legally reject affordable housing projects. The Second District Court of Appeals, Division Four, issued its
More
New Mexico Attorney General Raúl Torrez has filed a federal lawsuit against Acting Attorney General Todd Blanche and the U.S. Department of Justice over withheld Epstein investigative files. The lawsuit, filed Wednesday,
More
NetDocuments has announced a significant move into the plaintiffs’ contingency fee lawyer market, marking a notable strategic expansion for the document management company. The decision to enter this specific legal market is
More
UK equities posted modest gains on Friday as surging oil prices boosted energy stocks and Lloyds data pointed to renewed pressure on mortgage borrowers. By 07:30 GMT, the FTSE 100 (LSE:JD.) had
More
The US stock market posted a sharp rally on Tuesday, with major indices climbing broadly as investor confidence showed notable signs of recovery. Equities across multiple sectors moved higher in heavy trading
More
Bark Inc. (NYSE: BARK), the dog-focused consumer products company, has reported second-quarter CY2026 sales figures that surpassed analyst estimates, sending shares sharply higher. The revenue beat caught the attention of investors who
More